patent foramen ovale closure

Original Contribution

Amplatzer or Figulla Flex II Occluder: A Comparative Study of Outcomes After Transcatheter Patent Foramen Ovale Closure

02/23/2024

Stefan Toggweiler, MD; Federico Moccetti,MD; Nina Conrad, MS; Lucca Loretz, MD; Mehdi Madanchi, MD; Matthias Bossard, MD; Adrian Attiger-Toller, MD; Florim Cuculi, MD; Mathias Wolfrum, MD

Stefan Toggweiler, MD; Federico Mocce...

The present report compares results of 2 widely used, self-expanding, double-disc occluders: the Abbott Amplatzer PFO occluder and the Occlutech Figulla Flex II PFO occluder.

The present report compares...

02/23/2024

Journal of Invasive Cardiology

Review

Various Techniques for Transcatheter Retrieval of Atrial Septal Defect or Patent Foramen Ovale Closure Devices: A Systematic Review

02/23/2024

Alireza Khosravi, MD¹; Seyedeh Mahnaz Mirbod, MD²; Maryam Boshtam, PhD³; Farzad Shahsanaei, MD⁴; Erfan Zaker, MSc⁵; Marzieh Tajmirriahi, MD⁶; Arsalan Khaledifar, MD⁷; Seyedeh Mojgan Mirbod, MD⁸; Mohammad Reza Movahed, MD^9,10

Alireza Khosravi, MD1; Seyedeh Mahnaz...

This manuscript describes a systematic review of the techniques used to retrieve atrial septal defect closure devices, as well as their success rates, complications, and limitations

This manuscript describes a...

02/23/2024

Journal of Invasive Cardiology

Original Contribution

Closure of Long-Tunnel PFOs With the Coherex Flatstent EF – A Tailored Approach

09/02/2015

Michael J. Mullen , MD;

Ulf Landmesser , MD;

Markus Reinthaler , MD;

Suneil K. Aggarwal , MD;

Aral Mert , MD;

Santi Lim , MD;

Carsten Skurk , MD;

Despite rapid progress in device technologies for PFO closure over the past decade, long-tunnel anatomies still constitute a challenge. The present study investigated the performance of a novel in-tunnel device (Flatstent EF; Coherex Medical)...

Despite rapid progress in device...

09/02/2015

Journal of Invasive Cardiology

Interview

VDM Speaks with Scott E. Kasner, MD, MSCE

03/31/2011

Scott E. Kasner, MD

What do we know thus far from the clinical trials about the efficacy and safety of patent foramen ovale (PFO) closure for cryptogenic stroke?

What do we know thus far from...

03/31/2011

Vascular Disease Management

Interview

VDM Speaks with John F. Rhodes, MD, U.S. Cardiology Principal Investigator for the REDUCE Trial

02/02/2011

Please give us an overview of the REDUCE clinical study.

Please give us an overview of...

02/02/2011

Vascular Disease Management

Case Report

Treatment of Residual Shunt After Percutaneous Closure of Patent Foramen Ovale With a Second CardioSEAL Device

09/05/2008

Paradoxical embolism (through a right-to-left shunt) as a mechanism of stroke has been described as early as 1877.Patent foramen ovale (PFO) is present in up to 50% of patients with cryptogenic stroke. Currently, secondary prevention of...

Paradoxical embolism (through a...

09/05/2008

Vascular Disease Management